New joint MHRA-NICE approval pathway and an improved Integrated Science Advice (ISA) service

MHRA and NICE are launching an aligned pathway together with an improved Integrated Scientific Advice service to accelerate patient access to medicines and provide a more efficient route for industry. This will offer a single-entry point, meeting and report, and…

Read MoreNew joint MHRA-NICE approval pathway and an improved Integrated Science Advice (ISA) service

European Commission proposes pharmaceuticals reform for more accessible, affordable and innovative medicines

Last updated: 9 March 2026 To view updates, click on the ‘+’ sign below. The European Commission is proposing to revise the EU’s pharmaceutical legislation – the largest reform in over 20 years in order to make it more agile, flexible, and…

Read MoreEuropean Commission proposes pharmaceuticals reform for more accessible, affordable and innovative medicines

Amendments to the EU variations regulation and new variations guidelines

EU Variations update

Last updated: 4 March 2026 To view updates, click on the ‘+’ sign below. This post provides information on the changes to the EU the variation Regulation (EC) No 1234/2008 and guidelines. Legal Framework What are some of the changes introduced…

Read MoreAmendments to the EU variations regulation and new variations guidelines